Home parenteral support with compounded nightly infusions reduces catheter-related bloodstream infections and treatment burden in severe Gitelman syndrome.
A 65-year-old woman with severe Gitelman syndrome was managed with home parenteral support (HPS) for 15 years, experiencing multiple catheter-related bloodstream infections and thromboses. Transition to a shared care model with compounded nightly infusions eliminated further infections and catheter exchanges, and improved quality of life by allowing uninterrupted sleep.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Home parenteral support with compounded nightly infusions reduces catheter-related bloodstream infections and treatment burden in severe Gitelman syndrome. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Home parenteral support with compounded nightly infusions reduces catheter-related bloodstream infections and treatment burden in severe Gitelman syndrome.
This conclusion is most relevant to: A 65-year-old woman with severe Gitelman syndrome requiring daily intravenous electrolyte replacement..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Home Parenteral Support in Severe Gitelman Syndrome: A Case Report. (Clinical case reports, 2026) —
How It Works
The proposed biological pathway:
- ▸Compounded home infusions allow continuous overnight electrolyte delivery
- ▸Eliminates need for multiple daily connections and disconnections
- ▸Reduces manipulation of central venous catheter
- ▸Result: No further CRBSIs or catheter exchanges, improved sleep and quality of life
Who Might Benefit
Evidence fit by population:
- ▸A 65-year-old woman with severe Gitelman syndrome requiring daily intravenous electrolyte replacement.
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Single case report, not generalizable to all GS patients
- ▸No control group or statistical comparison; outcomes are descriptive
Frequently Asked Questions
What is Gitelman syndrome?▼
Gitelman syndrome is a rare autosomal recessive renal tubular disorder characterized by hypokalaemia, hypomagnesemia, metabolic alkalosis, and hypocalciuria.
How was home parenteral support administered in this case?▼
High-dose intravenous electrolyte replacement was given as part of a home parenteral support regimen, later rationalized to compounded nightly infusions that allowed the patient to sleep through the night without additional connections.
What complications occurred with long-term home parenteral support?▼
Multiple catheter-related bloodstream infections and catheter-related venous thromboses occurred over 15 years of HPS.
Did the transition to a shared care model improve outcomes?▼
Yes, after transitioning to an accredited multidisciplinary intestinal failure unit with compounded nightly infusions, no further CRBSIs or catheter exchanges occurred, and treatment burden was reduced.
References
- 1.Martin G, Fahal I, Mehta S. “Home Parenteral Support in Severe Gitelman Syndrome: A Case Report..” Clinical case reports, 2026. PMID: 42487655 DOI: 10.1002/ccr3.73210